Search

See Pharmaceutical Reviews Update – Issue 21 for important news and information regarding CADTH’s drug review programs. Highlights from this issue include:

• a new recommendation template for reimbursement reviews
• revisions to the CADTH pharmacoeconomic requirements
• updates to the fee schedule for CADTH pharma...

See Pharmaceutical Reviews Update – Issue 21 for important news and information regarding CADTH’s drug review programs. Highlights from this issue include:

• Update for Patients and Communities
• Revised target dates for pERC meetings
• Revised timelines for posting clinician group input

See Pharmaceutical Reviews Update – Issue 20 for important news and information regarding CADTH’s drug review programs. Highlights from this issue include:

• Clarifications for pharmacoeconomic requirements
• Revised process for uploading advance notification and pre-submission meeting forms
• Reminders for those ...

See Pharmaceutical Reviews Update – Issue 19 for important news and information regarding CADTH’s drug review programs. Highlights from this issue include:

• New guidance for providing patient input
• New webpage for provisional funding algorithms

See Pharmaceutical Reviews Update – Issue 18 for important news and information regarding CADTH’s drug review programs. Highlights from this issue include:

• updates on communications and web pages for CADTH drug reimbursement reviews
• updates on clinician group input.

See Pharmaceutical Reviews Update – Issue 17 for important news and information related to CADTH’s drug review programs. Highlights from this issue include:

• new procedures for CADTH drug reimbursement reviews
• a revised provisional algorithm process
• a revised CADTH fee schedu...

See Pharmaceutical Reviews Update – Issue 16 for important news and information related to CADTH’s drug review programs. Highlights from this issue include:

• a consultation on CADTH’s drug reimbursement review procedures
• a consultation on the Health Canada, CADTH, and INESSS aligned review ...

Highlights from this issue include:

• Questions and answers regarding CADTH’s pharmaceutical review programs and COVID-19
• Postponement of consultations on CADTH’s aligned drug review processes
• New Canadian Plasma Protein Product Expert Committee
• Revised pr...

See Pharmaceutical Reviews Update – Issue 14 for important news and information regarding CADTH’s drug review programs. Highlights from this issue include:

• A minor revision to the procedure for the sponsor’s review of initial CADTH pCODR Clinical and Economic Reports
• Pending consultation o...

Highlights from this issue include:

• New consolidated document for pCODR procedures and guidelines
• Clarifications regarding economic submission requirements
• Update for patients and communities